BioCorRx (BICX) Gross Profit (2011 - 2026)
BioCorRx's Gross Profit was $189,355 in Q1 2026, up 40.4% from $134,899 a year earlier.
Powered by 
Analysis
BioCorRx (BICX) Gross Profit (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioCorRx's Gross Profit was $324,254 through Mar 31, 2026, up 133.4% year-over-year; for FY2024, it came in at $5,998, down 88.7% from FY2023.
- Gross Profit shows a five-year compound annual growth rate of -48.1% (FY2019 to FY2024).
- In earlier years, Gross Profit was $53,174 in FY2023 (-73.2%), $198,562 in FY2022 (+368.4%), $42,391 in FY2021 (+58.9%) and $26,673 in FY2020 (-83.2%).
- The Q1 2026 figure marks the highest quarterly Gross Profit since Q1 2016.
- The best year-over-year quarter for Gross Profit over five years was Q4 2022 (growth of 563.6%); the worst was Q1 2024 (a decline of 93.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | BioCorRx | 830.00 | -906,148.00 | -56,997.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -56,997.00 |
| Mar 31, 2026 | 189,355.00 |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 276,412.00 |
| Jun 30, 2025 | 178,238.00 |
| Mar 31, 2025 | 134,899.00 |
| Dec 31, 2024 | -65,036.00 |
| Sep 30, 2024 | -123,376.00 |
| Jun 30, 2024 | -301,257.00 |
| Mar 31, 2024 | -182,800.00 |
| Dec 31, 2023 | -116,213.00 |
| Sep 30, 2023 | -39,696.00 |
| Jun 30, 2023 | 9,259.00 |
| Mar 31, 2023 | 31,766.00 |
| Dec 31, 2022 | 74,204.00 |
| Sep 30, 2022 | 92,098.00 |
| Jun 30, 2022 | -101,295.00 |
| Mar 31, 2022 | 18,983.00 |
| Dec 31, 2021 | -176,300.00 |
| Sep 30, 2021 | -141,764.00 |
API Access
BioCorRx Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();